1933 Industries Inc (TGIFF)
0.0147
0.00 (0.00%)
USD |
OTCM |
Apr 19, 09:36
1933 Industries Cash from Financing (TTM): -0.5588M for Jan. 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -0.5588M |
October 31, 2023 | -0.0939M |
July 31, 2023 | -0.1986M |
April 30, 2023 | 1.216M |
January 31, 2023 | 1.178M |
October 31, 2022 | 0.9281M |
July 31, 2022 | 1.209M |
April 30, 2022 | -0.3436M |
January 31, 2022 | 3.972M |
October 31, 2021 | 4.20M |
July 31, 2021 | 4.756M |
April 30, 2021 | 6.172M |
January 31, 2021 | 1.609M |
October 31, 2020 | 0.387M |
July 31, 2020 | 0.7821M |
April 30, 2020 | 9.137M |
January 31, 2020 | 15.53M |
October 31, 2019 | 16.38M |
July 31, 2019 | 27.48M |
April 30, 2019 | 17.50M |
January 31, 2019 | 12.22M |
October 31, 2018 | 21.34M |
July 31, 2018 | 14.44M |
April 30, 2018 | 16.15M |
January 31, 2018 | 19.27M |
Date | Value |
---|---|
October 31, 2017 | 10.37M |
July 31, 2017 | 5.337M |
April 30, 2017 | |
January 31, 2017 | |
October 31, 2016 | |
July 31, 2016 | |
April 30, 2016 | |
January 31, 2016 | |
September 30, 2015 | -0.0241M |
June 30, 2015 | -0.1418M |
March 31, 2015 | 0.0553M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.1983M |
June 30, 2014 | 0.2388M |
March 31, 2014 | 0.0412M |
December 31, 2013 | 0.0412M |
September 30, 2013 | 0.0409M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 1.148M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.5588M
Minimum
Jan 2024
27.48M
Maximum
Jul 2019
5.562M
Average
1.413M
Median
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |
Lexaria Bioscience Corp | 6.862M |
Xenon Pharmaceuticals Inc | 353.52M |